Serum Long-Chain n-3 Polyunsaturated Fatty Acids and Risk of Hospital Diagnosis of Atrial Fibrillation in Men | Zendy

Jyrki K. Virtanen | Zendy; Jaakko Mursu | Zendy; Sari Voutilainen | Zendy; TomiPekka Tuomainen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Serum Long-Chain n-3 Polyunsaturated Fatty Acids and Risk of Hospital Diagnosis of Atrial Fibrillation in Men

Author(s) -

Jyrki K. Virtanen,

Jaakko Mursu,

Sari Voutilainen,

TomiPekka Tuomainen

Publication year - 2009

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.109.852657

Subject(s) - docosapentaenoic acid , docosahexaenoic acid , medicine , eicosapentaenoic acid , hazard ratio , polyunsaturated fatty acid , atrial fibrillation , myocardial infarction , population , cardiology , heart failure , confidence interval , proportional hazards model , endocrinology , fatty acid , biochemistry , biology , environmental health

Atrial fibrillation (AF) is a common cardiac arrhythmia. Regular fish consumption has been shown to reduce the risk of AF in some but not all studies. Long-chain n-3 polyunsaturated fatty acids (PUFAs) from fish have been suggested to account for these beneficial effects. We tested this hypothesis by studying the association between the serum long-chain n-3 PUFAs eicosapentaenoic acid, docosapentaenoic acid, and docosahexaenoic acid and risk of AF in men.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research